Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 56Gastrointestinal 42Genitourinary 38Head & Neck 28Gynecologic 19Tumor-Agnostic 17Thoracic 16Lymphoid 12CNS 12Other hematologic neoplasm 11Sarcoma 8Dermatologic 6Plasma cell 5Endocrine 4Other solid neoplasm 3Other 3Other neoplasm 1NET 1Myeloid 1Classical hematology 1

Conditions

Cancer-related Venous Thromboembolism 1

Interventions

Cyclophosphamide 24fludarabine phosphate 18Whole-Body Irradiation 17fludarabine 16Mycophenolic Acid 16Tacrolimus 12Peripheral Blood Stem Cell Transplantation 12Busulfan 12Melphalan 11apixaban 10Biopsy 7Rivaroxaban 6Granulocyte Colony-Stimulating Factor 6Specimen Handling 5Filgrastim 5Cyclosporine 5Azacitidine 5thymoglobulin 4X-Rays 4Sirolimus 4Rituximab 4Injections 4Enoxaparin 4Decitabine 4Bone Marrow Transplantation 4Aspirin 4Antilymphocyte Serum 4venetoclax 3pegylated granulocyte colony-stimulating factor 3hetrombopag 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Surveys and Questionnaires × Classical hematology × 1 year × Clear all
NCT03407469 2026-05-20

Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

M.D. Anderson Cancer Center

Recruiting
260 enrolled
Classical hematology

Cancer-related Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡